IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
Authors
Keywords
-
Journal
Frontiers in Materials
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-25
DOI
10.3389/fmats.2022.944930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
- (2022) Rony Abdi Syahputra et al. MOLECULES
- Advanced drug delivery system against ischemic stroke
- (2022) Shanshan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Dually acid- and GSH-triggered bis(β-cyclodextrin) as drugs delivery nanoplatform for effective anticancer monotherapy
- (2021) Jian Chen et al. NANOTECHNOLOGY
- Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy
- (2021) Zhongying Gong et al. ACS Applied Materials & Interfaces
- Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways
- (2021) Leonie Schürmann et al. CANCER LETTERS
- Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine
- (2020) María Pulido et al. Cancers
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin
- (2019) Parisa Yousefpour et al. Small
- Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts
- (2019) V. Quagliariello et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice
- (2019) Yao Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair
- (2019) José R. García et al. BIOMATERIALS
- Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
- (2018) Curtis J. Perry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Co-delivery of Doxorubicin and Interferon-gamma by Thermosensitive Nanoparticles for Cancer Immunochemotherapy
- (2018) Yijia Yin et al. MOLECULAR PHARMACEUTICS
- C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease
- (2018) Antoine Dufour et al. Nature Communications
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies
- (2016) Salyan Bhattarai et al. JOURNAL OF AUTOIMMUNITY
- SENP1 regulates IFN-γ−STAT1 signaling through STAT3−SOCS3 negative feedback loop
- (2016) Tingting Yu et al. Journal of Molecular Cell Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started